Ask Mallard
Study design

Equivalence trial

4 min read

An equivalence trial tests whether two treatments differ by less than clinically justified limits in both directions.

NHMRC EVIDENCE LEVEL · 2009Level II · InterventionProvisional design classification. Study quality and certainty of findings require separate appraisal.
Why this level?Participants or clusters are randomly allocated to concurrent comparison groups. NHMRC 2009 source

Random allocation supports a treatment comparison, but equivalence also depends on justified limits, sensitive measurement, adherence and credible handling of missing outcomes.

Fit

When to use it, and when not to

Use it when

  • You need to exclude important differences in either direction.
  • A new treatment may offer practical benefits even if its clinical effect is similar.

Not when

Before you start

What you need

Decide these first
  1. The outcome, time point and treatment contrastDefine the population, scale and handling of treatment changes.
  2. Two clinical equivalence limitsJustify the limits with external evidence before enrollment or outcome review.
  3. A margin-based sample-size planUse the expected difference, variance, limits and chosen error rates.
  4. Analysis populations and missing outcomesPrespecify assignment-based and adherence-based questions with their assumptions.
It rests on these
  1. The trial could detect an important difference.How to check: Protect treatment contrast, adherence and outcome measurement quality.
  2. The limits are clinically defensible.How to check: Explain why differences inside them are acceptable for the intended use.
  3. Missing outcomes have a stated model.How to check: Justify missing at random if used; assess departures that favor apparent similarity.

Plain language

How it works

Randomize and conceal allocation as in other trials. Define the clinical limits before outcomes are known. Preserve study conduct that could reveal a real treatment difference. Plan sample size using the margin-based test.

The study structure
Justify both clinical limits; then Randomize with concealed allocation; then Protect adherence and outcome measurement; then Read the interval against both limits.Equivalence trialJustify both clinical limitsRandomize with concealed allocationProtect adherence and outcome measurementRead the interval against both limits
Conceptual diagram. It shows the structure of the idea, not data from any study.
What the answer means

Piaggio and colleagues explain reporting for equivalence trials; Schuirmann develops the two one-sided testing rule. The trial design includes its margin and conduct, while the linked analysis page explains the test.

Worked example

A worked example

Invented for illustration
Setting
A large randomized trial compares two ways of delivering rehabilitation.
Question
Can the mean outcome difference be kept within prespecified limits of -5 and 5 points?
Approach
Assume a difference of 1 point and standard error of 2. Use normal Wald tests with one-sided alpha 0.05.
Result
The matching 90% interval is -2.29 to 4.29 points. The larger one-sided p-value is 0.023.
What it means
Both bounds lie inside the limits, supporting equivalence for this outcome and margin. The result does not prove identical effects.

In practice

Recent studies PubMed search · not vetted

Searching PubMed…

Watch out

Common mistakes

The one to remember

A nonsignificant superiority test does not establish equivalence; poor adherence or missing outcomes can hide important treatment differences.

  • Selecting limits after seeing results.Instead: Choose limits from clinical needs and external evidence first.
  • Assuming intention-to-treat always gives a conservative equivalence test.Instead: Examine adherence, missingness and the assumptions behind each analysis population.

Inside Mallard

How Mallard uses this

Plans do not link to this design yet. Learn search and the Atlas offer it as a reference.

No Mallard code example points to this page.
Atlas node design.equivalence_trial, the id a plan cue records.

How to report it

Use the CONSORT extension for noninferiority and equivalence trials. Report both prespecified limits and their rationale, allocation, sample-size assumptions, analysis populations, adherence, missing outcomes and confidence interval. A reporting guideline is not a design manual: use it to make the study transparent, not as a substitute for careful design. Check the target journal's own requirements as well, which this page cannot know.

Related Learn pages

Related designs and methods

Evidence

Sources & further reading

  1. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement (opens in a new tab) · JAMA · doi 10.1001/jama.2012.87802
  2. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability (opens in a new tab) · J Pharmacokinet Biopharm · doi 10.1007/BF01068419
Prepared with AI assistance. PubMed titles, authors, years and DOIs checked on 2026-11-07. Record verified, confirm it supports this use. No independent professional approval is claimed.
Last source review: 2026-11-07
AI-generated educational content
Mallard uses reputable methodological and reporting sources, but this material may contain errors or omit important context. Verify important methodological decisions with the cited sources and, when appropriate, a qualified research methodologist or statistician.